Skip to main content
Download PDF
Download ePub

Discordance between the triglyceride glucose index and HOMA-IR in incident albuminuria: a cohort study from China

Lipids in Health and Disease volume 20, Article number: 176 (2021) Cite this article

Abstract

Background

To date, there have no study comparing the associations between TyG index and HOMA-IR on the risk of incident albuminuria. Accordingly, the objective of the present study is to use discordance analysis to evaluate the diverse associations between TyG index and HOMA-IR on the risk of incident albuminuria.

Methods

A community-based prospective cohort study was performed with 2446 Chinese adults. We categorized participants into 4 concordance or discordance groups. Discordance was defined as a TyG index equal to or greater than the upper quartile and HOMA-IR less than the upper quartile, or vice versa.

Results

During a median follow-up period of 3.9 years, 203 of 2446 participants developed incident albuminuria (8.3%). In the multivariable logistic analyses, the high TyG index tertile group was associated with a 1.71-fold (95% confidence interval (CI) 1.07–2.72) higher risk of incident albuminuria, comparing with the low tertile group. Participants in TyG (+) & HOMA-IR (−) group had a greater risk of incident albuminuria compared with those in TyG (−) & HOMA-IR (−) group after multivariate adjustment. Subgroup analyses showed that low HOMA-IR and discordantly high TyG index was closely related to a highest risk of incident albuminuria in cardiovascular metabolic disorder subjects.

Conclusions

Participants with a discordantly high TyG index had a significantly greater risk of incident albuminuria, especially in metabolic dysfunction subjects. The TyG index might be a better predictor of early stage of chronic kidney disease than HOMA-IR for subjects with metabolic abnormality.

Background

Chronic kidney disease (CKD), a major disease burden, affects 8 to 16% of the population worldwide [1, 2]. Globally, metabolic disorders are the most common reasons for CKD [3]. Since extensive evidence has confirmed the strong association between CKD and an increased risk of cardiovascular disease [4, 5]. Dysregulated metabolic factors, including diabetes mellitus, hypertension and dyslipidaemia, play leading roles in mediating this relationship, the early identification of CKD is critical for preventing clinical cardiovascular events. Additionally, large-scale studies have proven that albuminuria is a sensitive biological marker of progression of kidney diseases in early stage of CKD [6], and increased urinary albumin excretion is also an important indicator of cardiovascular metabolic risk factors [7, 8].

Insulin resistance (IR) is an early metabolic change in individuals with CKD [9]. Since the hyperinsulinaemic-euglycaemic clamp (HIEC) is a well-accepted ‘gold standard’ approach for evaluating IR, the homeostasis model assessment of IR (HOMA-IR) is a relatively most widely used tool to assess IR. Moreover, considering the convenience of implementation, researchers often use the upper quartile of HOMA-IR as the standard in population research. With regard to triglycerides (TGs) and high-density lipoprotein (HDL) cholesterol are components of metabolic disorders [10]. Previous studies have reported that lipid ratios, such as TG/HDL cholesterol, the non-HDL cholesterol/HDL cholesterol and triglyceride-glucose (TyG) index, are good indicators of the early identification of IR and have been widely used in clinical practice [11]. Moreover, the TyG index, calculated by fasting glucose and triglycerides, has been shown to perform better than HOMA-IR [12] and to be significantly correlated with HIEC [13].

To date, this kind of studies have rare explored the connection of the TyG index and albuminuria. A community-based study designed by Zhao et al. [14] recently showed that, in elderly individuals, higher levels of the TyG index were closely related to a greater risk of CKD and microalbuminuria. However, no studies have compared the abilities of the TyG index and HOMA-IR to measure new-onset albuminuria in the general population. Therefore, the present study was carried out to use discordance analysis for the assessment and further comparison of the effects of TyG index and HOMA-IR on incident albuminuria risk.

Methods

Study design and participants

A community-based investigation was undertaken from June to August 2009 in the Songnan community, Baoshan District, Shanghai, China. A circumstantial introduction of this research population has been previously published [15, 16]. In total, 4012 participants underwent this examination at baseline. Serum and urine specimens were collected to detect TyG and urinary albumin-to-creatinine ratio (UACR). All participants were asked for to take part in a follow-up visit, of which 2883 individuals attended and tested for UACR between March and May in 2013. This current research was designed to explore the relationship of the TyG index and HOMA-IR to new-onset albuminuria. The exclusion criteria for the current analysis were subjects who (a) had self-reported kidney diseases at baseline (n = 36); (b) had UACR ≥ 30 mg/g or estimated glomerular filtration rate (eGFR) < 60 mL/min per 1.73 m2 (n = 390); (c) lacked UACR (n = 5); and (d) had missing data for TyG index or HOMA-IR (n = 6). Finally, 2446 individuals were included in this current study (Fig. 1).

Fig. 1
figure 1

Participant Flow Diagram of the Study. TyG, triglyceride glucose; HOMA-IR, homeostasis model assessment for insulin resistance; CKD, chronic kidney disease; UACR, urinary albumin-to-creatinine ratio; eGFR: estimated glomerular filtration rate

Full size image

The upper quartiles of baseline for the TyG index and HOMA-IR were calculated to classify participants into following 2 classes: low (lower than the upper quartiles) and high (equal to or higher than the upper quartiles). Then, participants were divided into 4 groups on the basis of the low/high value of the TyG index and HOMA-IR, as follows: TyG (−) & HOMA-IR (−), TyG (+) & HOMA-IR (−), TyG (−) & HOMA-IR (+) and TyG (+) & HOMA-IR (+) groups. Discordance groups were presented as the TyG (+) & HOMA-IR (−) and TyG (−) & HOMA-IR (+) groups.

The study protocol was approved by the Institutional Review Board of Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine. All participants have written informed consent.

Data collection and measurements

The trained physicians used a normalized questionnaire to collect information including sociodemographic features, education levels, lifestyle and history of chronic disease with two face-to-face interviews. The status of current smoking or drinking was defined as smoking or drinking frequently in the past half year. The International Physical Activity Questionnaire was often used to evaluate the degrees of physical activity [17]. Body weight, height and blood pressure (BP) were measured by experienced nurses on the basis of a standard protocol [15]. Participants were asked to rest for 5 min, and their seated blood pressure was measured three times on a nondominant arm with a 1 min interval. The average value of blood pressure was applied in the following analysis. Pulse pressure (PP) was obtained as the mean of three measurements by subtracting diastolic BP (DBP) from systolic BP (SBP).

Since the detection methods and instruments of blood samples and first-voided urine samples at early morning were previously described in published studies, repeat specification was no longer required here [15, 18, 19]. The TyG index was obtained by the formula: ln (fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2) [13]. The HOMA-IR index was obtained as fasting insulin (IU/mL) × fasting glucose (mmol/L)/22.5 [20].

Definitions

New-onset albuminuria was regarded as a UACR level of 30 mg/g or higher. The definition of CKD was an eGFR ≤ 60 mL/min per 1.73 m2 or albuminuria. Hypertension was accepted as a SBP level of 140 mmHg or higher, DBP level of 90 mmHg or higher, or self-reported previous history of hypertension by professionals. The definition of diabetes was a fasting plasma glucose (FPG) level of 7.0 mmol/L or higher, 2-h glucose after 75-g oral glucose tolerance test (OGTT) level of 11.1 mmol/L or higher, glycated haemoglobin (HbA1c) level of 6.5% or higher, or self-reported diagnosis by physicians and taking hypoglycaemic medications on the basis of the 2010 American Diabetes Association (ADA) criteria.

Statistical analysis

All data were analysed on the SAS version 9.4 platform (SAS Institute, Cary, NC, USA). A two-tailed P value < 0.05 was considered statistically significant. Baseline variables were compared according to 4 concordance or discordance groups. Continuous data were shown as means ± standard deviation, while categorical variables were displayed as numbers (%). Differences in baseline characteristics among the 4 concordance or discordance groups were carried out by one-way analysis of variance or the χ2 test.

The relationships of the TyG index tertiles, HOMA-IR tertiles and the 4 concordance or discordance groups with new-onset albuminuria were explored using multivariate-adjusted logistic regression models. Covariates involved in the analysis included age, sex, status of current smoking or drinking, education levels, physical activity, HbA1c, PP, HDL cholesterol, LDL cholesterol, total cholesterol, BMI and medication usage of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).

Furthermore, stratified analysis of the 4 concordance or discordance groups with the risk of new-onset albuminuria was repeated according to the status of diabetes, hypertension and age categories (≥ 60 years old or < 60 years old).

Additionally, the above analyses were repeated on the outcome of incident CKD. The flow diagram was shown in Supplementary Fig. 1, and the results were also shown in the supplementary materials.

Results

Baseline characteristics of participants in 4 concordance or discordance groups according to the TyG index and HOMA-IR

Baseline demographic and clinical characteristics were compared across the 4 concordance or discordance groups according to low or high categories for the TyG index and HOMA-IR (Table 1). The average age of enrolled subjects was 59.17 years old, and 968 of them were men (39.6%). Age, current smoking status, education level, diabetes, hypertension, and dyslipidaemia were different among the 4 groups. Furthermore, participants in TyG (−) & HOMA-IR (+) group were more probable to get a higher body mass index (BMI), SBP, DBP, FPG, fasting insulin, post load glucose and LDL cholesterol in comparison with TyG (+) & HOMA-IR (−) group and had a higher prevalence of diabetes and hypertension. Scatterplots and prevalence of discordance and concordance defined according to the upper quartile values of TyG index and HOMA-IR were depicted in Supplementary Fig. 2.

Table 1 Baseline characteristics of the concordance and discordance according to low or high TyG index and HOMA-IR categories
Full size table

Relationship of the TyG index, HOMA-IR and concordance or discordance groups with new-onset albuminuria and CKD

Table 2 shows the odds ratios (ORs) of new-onset albuminuria in participants according to TyG index tertiles, HOMA-IR tertiles and 4 concordance or discordance groups. The prevalence rates of increased new-onset albuminuria were 5.4, 7.1, and 12.4% from the range of TyG index tertiles low to high, and 4.4, 8.1, and 12.4% of HOMA-IR tertiles, respectively. Compared with the low tertile, the high TyG index tertile (OR: 1.71; 95% CI 1.07–2.72) and the high HOMA-IR tertile (OR: 1.72, 95% CI 1.07–2.78) had a greater risk of developing new-onset albuminuria. Considering the discordance analysis, participants in TyG (+) & HOMA-IR (−) group had a higher risk of new-onset albuminuria than those in TyG (−) & HOMA-IR (−) group after adjustment of all covariates (OR: 1.69, 95% CI 1.04–2.75). However, there was no significant result in the risk of new-onset albuminuria in participants with low TyG but high HOMA-IR.

Table 2 Incidence of albuminuria using the TyG index, HOMA-IR and concordance/discordance groups
Full size table

Similarly, as shown in Supplementary Table 1, those in TyG (+) & HOMA-IR (−) group experienced a greater risk of incident CKD than those in TyG (−) & HOMA-IR (−) group (OR: 1.62, 95% CI 1.01–2.58), and the participants in TyG (+) & HOMA-IR (+) group developed the highest risk (OR: 1.95, 95% CI 1.21–3.12) of incident CKD.

Stratified analysis for associations between the concordance or discordance groups and new-onset albuminuria and CKD

Subgroup analysis was carried out to explore the association between the concordance or discordance groups and new-onset albuminuria in enrolled participants (Fig. 2). Compared with the TyG (−) & HOMA-IR (−) group, participants in TyG (+) & HOMA-IR (−) group contributed to a significantly higher risk of new-onset albuminuria in patients with diabetes (OR: 1.96, 95% CI 1.05–3.65), with hypertension (OR: 1.83, 95% CI 1.05–3.21) and who were aged>60 (OR: 2.29, 95% CI 1.19–4.39) after multivariable adjustment. The stratified analysis was repeated for the concordance/discordance groups with the outcome of incident CKD and the results were presented in Supplementary Table 2.

Fig. 2
figure 2

Stratified analysis of the association between concordance or discordance groups of TyG index and HOMA-IR with incident albuminuria. ORs (95% CIs) were adjusted for age, sex, current smoking, current drinking, education, physical activity, HbA1c, PP, HDL-cholesterol, LDL-cholesterol, total cholesterol, BMI and medication treatment of ACEIs or ARBs. TyG, triglyceride glucose; HOMA-IR, homeostasis model assessment for insulin resistance; OR, odds ratio; CI, confidence interval; PP, pulse pressure; BMI, body mass index; HbA1c, glycated hemoglobin; LDL, low density lipoprotein; HDL, high density lipoprotein; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers

Full size image

Discussion

This research observed that TyG index was significantly relevant to incident albuminuria in a dose–response manner after adjusting for confounding factors in middle-aged and older participants in China. Furthermore, the discordance analysis showed that participants in TyG (+) & HOMA-IR (−) group experienced a higher risk of incident albuminuria after full adjustment, indicating that the TyG index was more apparently relevant to incident albuminuria than the HOMA-IR. Notably, the risk of incident albuminuria was greatest among the subgroup analyses of individuals with a discordantly high TyG index, suggesting that the TyG index might be a more effective indicator in participants with metabolic abnormalities, such as diabetes, hypertension and ageing. According to what we know, this initial study compared the influence of the TyG index and HOMA-IR on the risk of incident albuminuria in general population firstly.

IR in CKD individuals is closely associated with risk factors resulting in cardiovascular diseases, and the underlying mechanisms may include chronic inflammation, oxidative stress and endothelial dysfunction [21]. The results from previous studies found that patients with early-stage CKD with near-normal creatinine had defects in the insulin-mediated metabolic pathway of glucose. A retrospective cohort research carried out in Korea by Jiang et al. [22] demonstrated that IR was positively associated with the development of albuminuria in healthy individuals without diabetes. Albuminuria is an early manifestation of CKD. In addition, it is also a predictive factor of cardiovascular diseases in subjects with or without diabetes. HIEC is the “gold standard” approach for IR, where as it is not practical to use HIEC in the clinic due to its time-consuming and labour-intensive nature. HOMA-IR is currently the most commonly applied clinical indicator to assess IR. A lot of researches have presented that HOMA-IR is strongly associated with the progression of albuminuria. Recently, the REACTION (Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal) study conducted in China [23] found that HOMA-IR was positively related to UACR in prediabetes or diabetes groups, but this relationship was not found in the normal glucose tolerance group. Another large prospective study showed that HOMA-IR quintiles were correlated with the incidence of CKD in adults without diabetes. In the current study, HOMA-IR was further confirmed to have a dose–response relationship with new-onset albuminuria in the general population.

Previous studies have demonstrated a close linkage between the TyG index and cardiovascular diseases. A study including healthy subjects demonstrated that an increasing TyG index was related to a greater risk of cardiovascular disease independent of diabetic status [24]. Limited researches have illustrated the relationship between TyG index and nephric disease. Only one community-based cross-sectional study [14] discovered that higher TyG index was related to elevated microalbuminuria (OR: 1.61, 95% CI 1.22–2.13) and CKD (OR: 1.67, 95% CI 1.10–2.50) risk. This finding was consistent with the present study. Furthermore, data from this study supported that the TyG index might be an improved IR surrogate marker compared with HOMA-IR in the early stage of renal disease. According to the present study, participants in TyG (+) & HOMA-IR (−) group experienced a significantly greater risk of incident albuminuria independent of traditional cardiovascular disease risk factors in discordant analysis, first elaborating the diagnostic value of the TyG index in the early stage of nephrotic damage.

Abnormal metabolic status such as diabetes and hypertension are established risk factors of cardiovascular diseases. Previous studies [25,26,27] have illustrated that diabetes and hypertension harmed the microvascular system, and the underlying mechanism between diabetes, hypertension and microcirculation might include hypertrophic remodelling in small vessels, endothelial dysfunction and vascular dysfunction at the capillary network. These ultimately lead to an increase in microvascular permeability to large molecules (such as albumin) and impaired insulin sensitivity. Since then, several epidemiological studies [28, 29] have reported the UACR as a predictive index of cardiovascular events and mortality in diabetes, hypertension and the general population. In the current study, the risk of incident albuminuria across the 4 concordance or discordance groups in different cardiovascular metabolic disorder groups was further investigated, showing that the TyG index performed more effective than HOMA-IR in identifying incident albuminuria risk in subjects with higher cardiovascular metabolic risk, such as diabetes status and hypertension status.

Ageing is related to IR to a certain content. A community-based study of participants aged ≥ 65 years old in northern Shanghai [14] obtained a result that elevated TyG index had a greater risk of new-onset microalbuminuria or CKD. Rather than comparing the TyG index with other markers of IR in ageing participants, they revealed an linkage between the TyG index and nephric dysfunction. In this research, through the discordance analysis with HOMA-IR, the results further proved that the TyG index could recognize early renal stage in elderly individuals, which could improve the early detection of diseases.

Comparisons with other studies and what does the current work add to the existing knowledge

Previous studies have demonstrated the associations between the two indexes mentioned above with microalbuminuria or CKD separately in specific populations, such as elderly individuals or those with diabetes [14, 23]. However, this study compared the performance of TyG index with HOMA-IR in general population. Meanwhile, TyG index implemented more effective than HOMA-IR at identifying new-onset albuminuria in subjects with metabolic disorders.

Study strengths and limitations

This current study has some strengths. This study directly compared the effectiveness of the TyG index and HOMA-IR at evaluating new-onset albuminuria risk in the general population for the first time and approved that the TyG index was better at identifying metabolic disorder subjects with new-onset albuminuria than HOMA-IR. There are also several limitations of this study that should be considered. First, this research is presented in a Chinese population aged more than 40 years old, which is not generalizable to other ethnic groups. Second, the length of the follow-up time (3.9 years follow-up) may not have been sufficient to completely capture the probable occurrence of albuminuria and CKD. Third, the widespread use of the TyG index as the best cut-off value as an alternative marker requires further research in future studies. Lastly, some underlying metabolic-related disorder factors that might influence the results were not considered in the current research, like primary triglyceride abnormalities.

Conclusion

This present study summarized that participants companying a discordantly high TyG index had a significantly greater incident albuminuria risk, especially in subjects with cardiovascular metabolic abnormalities. This conclusion supports the clinical value of the TyG index, with its readily available and reliable feature in clinical practice and could help clinicians identify the early stage of CKD in advance.

Availability of data and materials

The datasets generated during and/or analysed during the current study are not publicly available due to the data privacy policy of the cohort but are available from the corresponding author on reasonable request.

Abbreviations

ACEI:

angiotensin-converting enzyme inhibitor

ADA:

American Diabetes Association

ARB:

angiotensin receptor blocker

BMI:

body mass index

BP:

blood pressure

CI:

confidence interval

CKD:

chronic kidney disease

DBP:

diastolic blood pressure

eGFR:

estimated glomerular filtration rate

FPG:

fasting plasma glucose

HbA1c:

glycated haemoglobin

HDL:

high-density lipoprotein

HIEC:

hyperinsulinaemic-euglycaemic clamp

HOMA-IR:

homeostasis model assessment of insulin resistance

IR:

insulin resistance

LDL:

low-density lipoprotein

PP:

pulse pressure

OGTT:

oral glucose tolerance test

OR:

odds ratio

REACTION Study:

Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal Study

SBP:

systolic blood pressure

TG:

triglyceride

TyG:

triglyceride-glucose

UACR:

urinary albumin-to-creatinine ratio

References

  1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. https://doi.org/10.1016/S0140-6736(13)60687-X.

    Article  PubMed  Google Scholar 

  2. Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–33. https://doi.org/10.1016/S0140-6736(19)32977-0.

    Article  Google Scholar 

  3. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis. 2010;17(3):215–24. https://doi.org/10.1053/j.ackd.2010.02.001.

    Article  PubMed  Google Scholar 

  4. Chronic Kidney Disease Prognosis C. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. https://doi.org/10.1016/S0140-6736(10)60674-5.

    Article  Google Scholar 

  5. Mathew RO, Bangalore S, Lavelle MP, Pellikka PA, Sidhu MS, Boden WE, et al. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney Int. 2017;91(4):797–807. https://doi.org/10.1016/j.kint.2016.09.049.

    Article  PubMed  Google Scholar 

  6. Stevens PE, Levin A. Kidney disease: improving global outcomes chronic kidney disease guideline development work group M: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007.

    Article  PubMed  Google Scholar 

  7. Waheed S, Matsushita K, Sang Y, Hoogeveen R, Ballantyne C, Coresh J, et al. Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2012;60(2):207–16. https://doi.org/10.1053/j.ajkd.2012.03.011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, et al. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant. 2010;25(5):1560–7. https://doi.org/10.1093/ndt/gfp646.

    Article  CAS  PubMed  Google Scholar 

  9. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998;53(5):1343–7. https://doi.org/10.1046/j.1523-1755.1998.00898.x.

    Article  CAS  PubMed  Google Scholar 

  10. Kimm H, Lee SW, Lee HS, Shim KW, Cho CY, Yun JE, et al. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin. - usefulness of lipid ratios in Korean men and women. Circ J. 2010;74(5):931–7. https://doi.org/10.1253/circj.CJ-09-0571.

    Article  CAS  PubMed  Google Scholar 

  11. Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):146. https://doi.org/10.1186/s12933-014-0146-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. https://doi.org/10.1016/j.diabres.2011.05.030.

    Article  CAS  PubMed  Google Scholar 

  13. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51. https://doi.org/10.1210/jc.2010-0288.

    Article  CAS  PubMed  Google Scholar 

  14. Zhao S, Yu S, Chi C, Fan X, Tang J, Ji H, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the northern Shanghai study. Cardiovasc Diabetol. 2019;18(1):95. https://doi.org/10.1186/s12933-019-0898-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ning G, Bi Y, Wang T, Xu M, Xu Y, Huang Y, et al. Relationship of urinary bisphenol a concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis. Ann Intern Med. 2011;155(6):368–74. https://doi.org/10.7326/0003-4819-155-6-201109200-00005.

    Article  PubMed  Google Scholar 

  16. Lin L, Peng K, Du R, Huang X, Lu J, Xu Y, et al. Metabolically healthy obesity and incident chronic kidney disease: the role of systemic inflammation in a prospective study. Obesity (Silver Spring). 2017;25(3):634–41. https://doi.org/10.1002/oby.21768.

    Article  CAS  Google Scholar 

  17. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8(1):115. https://doi.org/10.1186/1479-5868-8-115.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wang T, Li M, Chen B, Xu M, Xu Y, Huang Y, et al. Urinary bisphenol a (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97(2):E223–7.

    Article  CAS  Google Scholar 

  19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191–2. https://doi.org/10.2337/diacare.21.12.2191.

    Article  CAS  PubMed  Google Scholar 

  21. Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087–108. https://doi.org/10.1152/ajprenal.00340.2016.

    Article  CAS  PubMed  Google Scholar 

  22. Jang CM, Hyun YY, Lee KB, Kim H. Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes. Endocrine. 2015;48(1):203–10. https://doi.org/10.1007/s12020-014-0242-x.

    Article  CAS  PubMed  Google Scholar 

  23. Gu S, Wang A, Ning G, Zhang L, Mu Y. Insulin resistance is associated with urinary albumin-creatinine ratio in normal weight individuals with hypertension and diabetes: the REACTION study. J Diabetes. 2020;12(5):406–16. https://doi.org/10.1111/1753-0407.13010.

    Article  CAS  PubMed  Google Scholar 

  24. Li S, Guo B, Chen H, Shi Z, Li Y, Tian Q, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci Rep. 2019;9(1):7320. https://doi.org/10.1038/s41598-019-43776-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001;103(9):1238–44. https://doi.org/10.1161/01.CIR.103.9.1238.

    Article  CAS  PubMed  Google Scholar 

  26. Akerstrom T, Laub L, Vedel K, Brand CL, Pedersen BK, Lindqvist AK, et al. Increased skeletal muscle capillarization enhances insulin sensitivity. Am J Physiol Endocrinol Metab. 2014;307(12):E1105–16. https://doi.org/10.1152/ajpendo.00020.2014.

    Article  CAS  PubMed  Google Scholar 

  27. Strain WD, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. https://doi.org/10.1186/s12933-018-0703-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sung KC, Ryu S, Lee JY, Lee SH, Cheong E, Hyun YY, et al. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality. J Am Heart Assoc. 2016;5(9):5(9). https://doi.org/10.1161/JAHA.116.003245.

    Article  CAS  PubMed Central  Google Scholar 

  29. Inoue K, Streja E, Tsujimoto T, Kobayashi H. Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. adults enrolled in the NHANES during 1999-2015. Ann Epidemiol. 2021;55:15–23. https://doi.org/10.1016/j.annepidem.2020.12.004.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The investigators are grateful to all participants for their cooperation in the study.

Funding

This work was supported by the grants from the National Key R&D Program of China (2017YFC1310700, 2018YFC1311800, 2018YFC1311705), the National Natural Science Foundation of China (81870560, 82070880, 81941017, 81770842, 81970706, 82022011), the Shanghai Municipal Government (18411951800), the Shanghai Shenkang Hospital Development Center (SHDC12019101, SHDC2020CR1001A, SHDC2020CR3069B), the Shanghai Jiaotong University School of Medicine (DLY201801), the Ruijin Hospital (2018CR002), and Shanghai Rising-Star Program (21QA1408100). The investigators are grateful to all participants for their cooperation in the study.

Author information

Author notes

  1. Wei Gao, Jialu Wang and Yan Chen contributed equally to this work.

Authors and Affiliations

  1. Songnan Town Community health Service Center, Baoshan District, Shanghai, China

    Wei Gao, Yan Chen, Hongmei Qiao, Xiaozhong Qian & Jinli Gao

  2. Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Rui-Jin 2nd Road, Shanghai, 200025, China

    Jialu Wang, Zhuojun Xin, Zhiyun Zhao, Tiange Wang, Yu Xu, Min Xu, Yufang Bi & Mian Li

  3. Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Rui-Jin 2nd Road, Shanghai, 200025, China

    Jialu Wang, Zhuojun Xin, Zhiyun Zhao, Tiange Wang, Yu Xu, Min Xu, Yufang Bi & Mian Li

Authors
  1. Wei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jialu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongmei Qiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaozhong Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhuojun Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhiyun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tiange Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Min Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yufang Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jinli Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: Jinli Gao, Mian Li, Yufang Bi; Methodology: Wei Gao, Jialu Wang, Yan Chen, Hongmei Qiao, Xiaozhong Qian, Zhuojun Xin; Formal analysis and investigation: Wei Gao, Jialu Wang, Yan Chen; Writing - original draft preparation: Wei Gao, Jialu Wang, Yan Chen; Writing - review and editing: Jinli Gao, Mian Li; Funding acquisition: Yufang Bi, Yu Xu, Min Xu, Tiange Wang; Resources: Min Xu, Zhiyun Zhao; Supervision: Jinli Gao, Mian Li, Yufang Bi. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Mian Li or Jinli Gao.

Ethics declarations

Ethics approval and consent to participate

Due to the anonymity of the data, research ethics has been approved in previous studies, so there was no need to reapply in this study.

Consent for publication

Not applicable.

Competing interests

All authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary Table 1 Incidence of CKD using the TyG index, HOMA-IR and concordance/discordance groups (N=2448). Supplementary Table 2 Stratified analyses of the association between concordance/discordance groups and CKD. Supplementary Figure 1 Participant Flow Diagram of CKD outcome. Supplementary Figure 2 Scatterplots and prevalence of discordance and concordance defined according to the upper quartile values of TyG index and HOMA-IR.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, W., Wang, J., Chen, Y. et al. Discordance between the triglyceride glucose index and HOMA-IR in incident albuminuria: a cohort study from China. Lipids Health Dis 20, 176 (2021). https://doi.org/10.1186/s12944-021-01602-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12944-021-01602-w

Keywords

Lipids in Health and Disease

ISSN: 1476-511X